EN HU

Kónya Bálint

Kónya Bálint

Publication list

2020
1.
Goyard, D., Kónya, B., Czifrák, K., Larini, P., Demontrond, F., Leroy, J., Balzarin, S., Tournier, M., Tousch, D., Petit, P., Duret, C., Maurel, P., Docsa, T., Gergely, P., Somsák, L., Praly, J. P., Azay-Milhau, J., Vidal, S.: Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
Org. Biomol. Chem. 18 (5), 931-940, 2020.
Journal metrics:
Q2 Biochemistry
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
2016
2.
Goyard, D., Kónya, B., Chajistamatiou, A. S., Chrysina, E. D., Leroy, J., Balzarin, S., Tournier, M., Tousch, D., Petit, P., Duret, C., Maurel, P., Somsák, L., Docsa, T., Gergely, P., Praly, J. P., Azay-Milhau, J., Vidal, S.: Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
Eur. J. Med. Chem. 108, 444-454, 2016.
Journal metrics:
Q1 Drug Discovery
Q1 Medicine (miscellaneous)
Q1 Organic Chemistry
Q1 Pharmacology
2013
3.
Nagy, L., Docsa, T., Szántó, M., Brunyánszki, A., Hegedűs, C., Márton, J., Kónya, B., Virág, L., Somsák, L., Gergely, P., Bai, P.: Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N'-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism.
PLoS One. 8 (7), e69420-, 2013.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2012
4.
Nagy, V., Felföldi, N., Kónya, B., Praly, J. P., Docsa, T., Gergely, P., Chrysina, E. D., Tiraidis, C., Kosmopoulou, M. N., Alexacou, K. M., Konstantakaki, M., Leonidas, D. D., Zographos, S. E., Oikonomakos, N. G., Kozmon, S., Tvaroška, I., Somsák, L.: N-(4-Substituted-benzoyl)-N'-(beta-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.
Bioorg. Med. Chem. 20 (5), 1801-1816, 2012.
Journal metrics:
Q2 Biochemistry
Q1 Clinical Biochemistry
Q1 Drug Discovery
Q2 Molecular Biology
Q2 Molecular Medicine
Q1 Organic Chemistry
D1 Pharmaceutical Science
5.
Kónya, B., Docsa, T., Gergely, P., Somsák, L.: Synthesis of heterocyclic N-(beta-d-glucopyranosyl)carboxamides for inhibition of glycogen phosphorylase.
Carbohydr. Res. 351, 56-63, 2012.
Journal metrics:
Q2 Analytical Chemistry
Q3 Biochemistry
Q2 Medicine (miscellaneous)
Q2 Organic Chemistry
2010
6.
Somsák, L., Bokor, É., Czifrák, K., Kónya, B., Kun, S., Tóth, M.: A glikogén foszforiláz glükózanalóg gátlószerei, mint potenciális antidiabetikumok.
Magy. Kém. F. 116 (1), 19-30, 2010.
7.
Cheng, K., Liu, J., Sun, H., Bokor, É., Czifrák, K., Kónya, B., Tóth, M., Docsa, T., Gergely, P., Somsák, L.: Tethered derivatives of D-glucose and pentacyclic triterpenes for homo/heterobivalent inhibition of glycogen phosphorylase.
New J. Chem. 34, 1450-1464, 2010.
Journal metrics:
Q2 Catalysis
Q1 Chemistry (miscellaneous)
Q1 Materials Chemistry
2008
8.
Somsák, L., Hüse, C., Felföldi, N., Kónya, B., Kútvölgyi, K., Bokor, É., Czifrák, K.: Assessment of synthetic methods for the preparation of N-beta-D-glucopyranosyl-N'-substituted ureas, -thioureas and related compounds.
Carbohydr. Res. 343 (12), 2083-2093, 2008.
Journal metrics:
Q2 Analytical Chemistry
Q2 Biochemistry
Q1 Medicine (miscellaneous)
Q2 Organic Chemistry
DEENK University of Debrecen
© 2012 University of Debrecen